VeriMomБезопасен ли sodium chitosan caprylamide hydroxypropylsulfonate при беременности?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.
Related ingredients
Frequently asked questions
- Безопасен ли sodium chitosan caprylamide hydroxypropylsulfonate при беременности?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.
- Безопасен ли sodium chitosan caprylamide hydroxypropylsulfonate при грудном вскармливании?
- No evidence of reproductive or lactation toxicity; no data suggesting systemic absorption in adults or transfer into breast milk. No harmonised CLP flags or CIR/SCCS concerns were identified. Therefore default low hazard and negligible exposure for breastfeeding mothers from topical cosmetic use.
- Безопасен ли sodium chitosan caprylamide hydroxypropylsulfonate для кожи малыша?
- No infant‑specific reproductive or systemic toxicity data were identified. The ingredient is a high‑molecular‑weight chitosan derivative and likely shows limited skin penetration, but infant skin barrier immaturity and higher surface‑area‑to‑weight justify an exposure score increased by +1 relative to adults. No evidence was found to increase hazard or mechanism scores for infants.
- Как VeriMom оценивает sodium chitosan caprylamide hydroxypropylsulfonate?
- VeriMom оценивает sodium chitosan caprylamide hydroxypropylsulfonate в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы sodium chitosan caprylamide hydroxypropylsulfonate при беременности?
- См. наш список безопасных альтернатив sodium chitosan caprylamide hydroxypropylsulfonate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.